bioMérieux Inc. plans Durham County expansion
BioMérieux Inc., a subsidiary of a France-based diagnostics company that has its U.S. corporate headquarters in Durham County, is planning to invest $48.3 million in an expansion project here that would create 44 jobs.
Gov. Pat McCrory and N.C. Commerce Secretary Sharon Decker announced Thursday an incentive award of up to $220,000 for the project.
The performance-based grant is contingent on the company’s getting a matching grant from the local government, according to the news release from the state officials. The money would be paid out only as the company meets certain performance targets.
BioMérieux provides diagnostic instruments, software and other products used to determine the source of disease or contamination.
Its products are used for diagnosing infectious diseases, as well as for detecting micro-organisms in agri-food, pharmaceutical and cosmetic products.
The company has 41 subsidiaries all over the world, and is present in 150 countries through a network of distributors.
The company’s U.S. subsidiary, which has its corporate headquarters in Treyburn Corporate Park in Durham County, is its largest subsidiary, said Marc Mackowiak, president and CEO of bioMérieux.
The company has more than 630 workers in its facility here, according to the announcement by McCrory and Decker.
The company manufactures blood culture media used in the diagnosis of blood infections at the facility here.
Allan Mohess, director of marketing and communications for the company, said the blood cultures are primarily used when a person may have sepsis, a severe blood infection.
Mackowiak said in an interview Thursday that the company is looking to expand the facility to increase its manufacturing capabilities.
“As you know, the emerging cultures, some are emerged – China, India – have very, very heavy demands,” Mackowiak said. “We need to be prepared for the future. The site in Durham is manufacturing for the world.”
Salaries for the jobs created in the expansion would vary by job function, according to the state’s release.
The average annual payroll for the new jobs would be $2.2 million. The company plans to create the jobs and make the investment across three years.
“BioMérieux has a long and treasured history with North Carolina. Its skilled and educated workforce has enabled us to become a leading innovator and supplier of diagnostic equipment,” Mackowiak said in the release.